Navigation Links
Nationally-Recognized Retinal Expert Returns to Gainesville, Joins Retina Specialty Institute

Gainesville, FL (PRWEB) May 15, 2013

Retina Specialty Institute is proud to welcome Shalesh Kaushal, M.D., Ph.D., to the Institute as a practitioner and researcher. Dr. Kaushal treats patients with all types of retinal diseases in the new office located at 6717 NW 11th Place, Suite C, Gainesville, Florida.

Dr. Kaushal earned his medical degree from Johns Hopkins University School of Medicine in Baltimore, Maryland and his Ph.D. from Massachusetts Institute of Technology. Dr. Kaushal completed his residency at the University of Southern California Doheny Eye Institute, and also completed surgical retina training at the Barnes Retina Institute/Washington University St. Louis as well as a medical retina fellowship at Moorfields Eye Hospital in London.

Dr. Kaushal previously headed up the retina division at the University of Florida in Gainseville. He is board certified in ophthalmology and is a nationally and internationally recognized researcher specializing in inherited degenerative retinal and macular diseases, and one of the first in his field to conduct gene therapy as a treatment. He is a widely published, peer-reviewed author and currently serves on the review boards of several leading medical journals.

Dr. Kaushal joins a team of world-class experts at Retina Specialty Institute (RSI), providing patients with the latest treatments in retina care. RSI is nationally recognized for clinical trials, drug development, treating macular degeneration and diabetic retinopathy with offices along the Gulf Coast from New Orleans, LA to Orlando, FL. For more information, including your nearest location, call 855-5RETINA (toll free) or visit


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Medical System Marketing Highlights Nationally-Recognized Stroke Care
2. Antibiotics Linked to Retinal Detachment Risk
3. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
4. New type of retinal prosthesis could better restore sight to blind, Stanford study says
5. Retinal Device Restores Sight to Blind Mice
6. UCIs Gavin Herbert Eye Institute receives $3 million for retinal degeneration research
7. Experts Offer Advice After Yankee Pitchers Trampoline Injury
8. NYU Langone experts present research, clinical advances at neurosurgeons meeting
9. Red Tide Likely in New England This Season, Experts Warn
10. No Proof That Gum Disease Causes Heart Disease, Experts Say
11. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: